OPK - OPKO Health Operating income before deduction of amortization

Graphic logo of OPKO Health (OPK)

Demand for laboratory testing provides OPKO Health, Inc. (OPK) with a steady cash flow. Effective management integrates diagnostics and pharmacology to launch new products, while BioReference's professional staff ensures the accuracy of analyses. EBITDA cash flow demonstrates current operating income trends, with 0.00 reflecting the latest metric value, confirming the business's financial stability.

Profit before payment of interest, taxes and amortization: OPKO Health (OPK) for 11/23/2025 - 11/11/2026

Summary analytical data breakdowns for OPKO Health (OPK)

- stock value and consensus price forecast:
Market Chart OPKO Health Corp.|OPK - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization OPKO Health|OPK - Total Company Value
- balance sheet equity data:
Net Assets per Share OPKO Health|OPK - Company Book Value|Market-to-Book Ratio opko.com|OPK - Aggregate Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Equity OPKO Health, Inc.|OPK - Long-Term Debt to Equity|Short-Term Debt to Capital OPKO Health Inc|OPK - Company Debts|Debts to Book Value OPKO Health|OPK - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings OPKO Health|Intermediate Coverage Ratio opko.com
- company profitability and valuation multiples indicators:
OPK - Net Profit|Expected Net Profit OPKO Health, Inc.|OPK - P/E Multiple|Forward P/E Multiple opko.com|OPK - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPKO Health|OPK - Operating profit before deduction of amortization|Earnings per share for the last four quarters OPKO Health|OPK - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months opko.com|OPK - Net earnings per share growth this year|Expected earnings per share trend next year OPKO Health, Inc.
Analysis of all company metrics:OPKO Health, Inc.
Finished products of OPKO Health

Absolute operating profit measures the actual cash flow from core operations before depreciation and taxes. This metric allows an investor to assess the internal efficiency of the business and its resilience to external shocks. By analyzing the EBITDA chart, one can identify hidden risks of capital freezing during a sharp decline in amplitude. For OPKO Health, Inc. (OPK), this indicator reflects the balance between stable demand for diagnostics and stringent insurance regulations. The vertical integration of biotechnology and laboratories here directly determines the volume of cash generated.

Competitor analysis for OPKO Health, Inc.

Operating income before deduction of amortization Agilent Corp (A)|Quest Diagnostics - Operating profit EBITDA|Operating income before deduction of amortization illumina.com ILMN|Exact Sciences Corporation (EXAS) - Profit before payment of interest, taxes and amortization|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Profit before interest, taxes and amortization Anbio Corp NNNN|Profit before payment of interest, taxes and amortization Sotera Health Company (SHC)|QDEL: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization CareDx Inc CDNA|Operating profit EBITDA Maravai LifeSciences Holdings MRVI|FLGT - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Standard BioTools Corp|CTKB (Cytek Biosciences, Inc.) - Operating profit before deduction of amortization|orasure.com - Income before deduction of interest, taxes and amortization|XGN (Exagen Inc) - Operating profit EBITDA|MDXH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA LUCD|PRE - Profit before interest, taxes and amortization|Operating profit EBITDA IMDX (Insight Molecular Diagnostics Inc)|Operating profit EBITDA Trinity Biotech PLC TRIB|PRPH - Profit before payment of interest, taxes and amortization|AIMD: Profit before payment of interest, taxes and amortization|CODX (Co-Diagnostics Corp) - Operating profit before deduction of amortization|HSCS: Company profit before taxes, interest and amortization|BMRA (Biomerica, Inc.) - Operating profit EBITDA|CDIO: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ONCO (Onconetix)|VRAX (Virax Biolabs Group Limited) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA BJDX (Bluejay)|Operating income before deduction of amortization Aspira Women's Health Inc (AWH)|AXDX - Profit before payment of interest, taxes and amortization|CNTG (Centogene) - Operating profit before amortization|ENZ: Operating profit EBITDA|Operating profit before deduction of amortization Fresh2 Group|Operating profit before deduction of amortization GENE|23andMe Inc (ME) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Psychemedics (PMD)